European Archives - Page 765 of 996 - European Medical Journal

Immatics Receives $58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies

The Series E funding was supported by existing investors including dievini Hopp Biotech holding, Wellington Partners, AT Impf GmbH and others.

Regulatory Approval in Europe Granted for Synthon’s Glatiramer Acetate 40 mg/ml

Nijmegen, the Netherlands, 05 October, 2017 – Synthon today announced that it has successfully concluded the decentralized procedures for…

CE Marking for World’s Only Integrated HIV Self-Test from Atomo Diagnostics Gives Access to Safe, Accurate and Reliable Self-Testing

Sydney, Australia, 10 October, 2017 – Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that…

Fire Ant Venom: A New Compound Discovered for Psoriasis Treatment

NTRIGUING new research has found that specific compounds present in fire ant venom have the potential to form a new, topical treatment for psoriasis…

Advanced Stage III Melanoma: Brand New Adjuvant Therapy Discovered

A NOVEL combination of dabrafenib and trametinib has proven a successful adjuvant therapy for Stage III BRAF-mutant melanoma patients, doubling…

Study Reveals Extent of Asthma Impact on Patient’s Lives

Quality of life in asthma patients is severely impacted, with many heavily limited in their day-to-day activities, and a worrying proportion experiencing…

Living with Spasmodic Dysphonia and the Impact on Relationships

Spasmodic dysphonia (SD) is a rare neurological condition and diagnosis is often missed, which can potentially cause immense suffering for patients, both…

Sailing Through September

With members of the EMJ team jetting off across Europe this month to attend a grand total of four medical congresses, which will of course be reviewed…

This September, EMJ Supports

With September having drawn to a close, the European Medical Journal (EMJ) looks back at the awareness campaigns we have supported this month: World…

Studying Protein Networks in Bowel Cancer

PROTEOMIC study of bowel cancer cells identifies common protein mutations and allows the prediction of treatment response….